Frequency of nasal carriage of staphylococcus aureus and its antimicrobial resistance pattern in patients on hemodialysis

Iranian Journal of Kidney Diseases

Volumn 4, Issue 3, 2010, Pages 218-222

  Ghasemian, Roya ^a   Najafi, Narges ^a   Makhlough, Atieh ^b   Khademloo, Mohammad ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carrier state; Drug resistance; Hemodialysis; Microbial sensitivity tests; Staphylococcus aureus

Indexed keywords

CATALASE; CEFALOTIN; CIPROFLOXACIN; CLINDAMYCIN; COAGULASE; COTRIMOXAZOLE; DEOXYRIBONUCLEASE; GENTAMICIN; MANNITOL; OXACILLIN; RIFAMPICIN; VANCOMYCIN;

ADULT; AGAR DILUTION; AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATE; BLOOD CULTURE; CATHETER INFECTION; DIABETIC PATIENT; DISK DIFFUSION; FEMALE; GRAM STAINING; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFECTION SENSITIVITY; INTRAVENOUS CATHETER; IRAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NOSE SMEAR; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IRAN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NOSE; RENAL DIALYSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77955403160     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EM. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis. 2003;37: 1629-38.
2. Berman SJ. Infections in patients with end-stage renal disease. An overview. Infect Dis Clin North Am. 2001;15:709-20, vii.
3. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int. 2001;60:1-13.
4. Lu PL, Tsai JC, Chiu YW, et al. Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant. 2008;23:1659-65.
5. Goldblum SE, Ulrich JA, Goldman RS, Reed WP. Nasal and cutaneous flora among hemodialysis patients and personnel: quantitative and qualitative characterization and patterns of Staphylococcal carriage. Am J Kidney Dis. 1982;2:281-6.
6. Zimakoff J, Bangsgaard Pedersen F, Bergen L, et al. Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal-dialysis centres in Denmark. The Danish Study Group of Peritonitis in Dialysis (DASPID). J Hosp Infect. 1996;33:289-300.
7. Kluytmans JA, Wertheim HF. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection. 2005;33:3-8.
8. Kirmani N, Tuazon CU, Murray HW, Parrish AE, Sheagren JN. Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med. 1978;138:1657-9.
9. Duran N, Ocak S, Eskiocak AF. Staphylococcus aureus nasal carriage among the diabetic and non-diabetic haemodialysis patients. Int J Clin Pract. 2006;60:1204-9.
10. Tokars JI, Frank M, Alter MJ, Arduino MJ. National surveillance of dialysis associated diseases in the United States, 2000. Semin Dial. 2002;15:162-71.
11. D'Agata EM. Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis. Clin Infect Dis. 2002;35:1212-8.
12. Ayliffe GA. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1997;24 Suppl 1:S74-9.
13. Boyce JM. Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? Jama. 1998;279:623-4.
14. National Committee for Clinical Laboratory Standards (NCCLS). Suggesting grouping of antimicrobial agent for routing testing and reporting. Approved standard M7-A5. Wayne, PA: NCCLS; 2000.
15. [No author listed]. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26 Suppl 1:S5-20.
16. National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. Wayne, PA: NCCLS; 2003.
17. Piraino B, Perlmutter JA, Holley JL, Bernardini J. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Perit Dial Int. 1993;13 Suppl 2:S332-4.
18. Goldblum SE, Ulrich JA, Goldman RS, Reed WP. Nasal and cutaneous flora among hemodialysis patients and personnel: quantitative and qualitative characterization and patterns of Staphylococcal carriage. Am J Kidney Dis. 1982;2:281-6.
19. Aminzadeh Z, Mastari Farahani A, Gachkar L. Prevalence of Staphylococcus aureus carriage in patients on hemodialysis and the pattern of antibacterial resistance. Iran J Clin Infect Dis. 2006;1:5-10.
20. Ghazvini K, Hekmat R. Nasal and skin colonization of Staphylococcus aureus in hemodialysis patients in Northeast of Iran. Iran J Kidney Dis. 2007;1:21-4.
21. Saxena AK, Panhotra BR, Chopra R. Advancing age and the risk of nasal carriage of Staphylococcus aureus among patients on long-term hospital-based hemodialysis. Ann Saudi Med. 2004;24:337-42.
22. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EM. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis. 2003;37: 1629-38.
23. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb Mortal Wkly Rep. 2002; 51:565-7.